The significance of CNPY2 in cancer biology is underscored by its overexpression across various solid tumors, including renal cell carcinoma (RCC) [8], prostate cancer [3], and hepatocellular carcinoma (HCC) [7]. This evidence concerns the gene CNPY2 and prostate cancer.